FIELD: ophthalmology. SUBSTANCE: composition comprises agent inhibiting production of IgE antibodies. Method resides in mixing agent inhibiting production of IgE antibodies with pharmaceutically acceptable carrier, filler or solvent. EFFECT: effective prevention of allergy. 10 cl, 3 dwg , 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| SUBSTANCE FOR TREATMENT OF INFLAMMATORY OR ALLERGIC DISEASES | 1990 |
|
RU2050156C1 |
| GLUTATHIONE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND A METHOD OF THEIR SYNTHESIS | 1991 |
|
RU2041201C1 |
| PHARMACEUTICAL COMPOSITION FOR TOPICAL USE FOR TREATMENT OF EYE AND NOSE ALLERGIC DISEASES | 1993 |
|
RU2130774C1 |
| EYE DROPS | 1991 |
|
RU2068260C1 |
| PHARMACEUTICAL COMPOSITION FOR GLAUCOMA TREATMENT | 1993 |
|
RU2102069C1 |
| METHOD OF PREPARING AN AQUEOUS SUSPENSION AND AN AQUEOUS OPHTHALMIC PREPARATION | 1992 |
|
RU2098094C1 |
| AGENT SHOWING ANTITUMOR ACTIVITY | 1990 |
|
RU2027442C1 |
| GLYCYRHETIC ACID DERIVATIVES, AND PROCESS FOR PREPARATION THEREOF | 1992 |
|
RU2065864C1 |
| AN AQUEOUS MEDICINAL COMPOSITION SHOWING CAPABILITY OF REVERSIBLE THERMOREGULATED GEL-FORMATION | 1993 |
|
RU2108112C1 |
| GLUTATHIO ALKYL ESTERS OF OXIDIZING TYPE AND METHOD FOR THEIR PRODUCTION | 1991 |
|
RU2043994C1 |
